johnson & johnson and us market Resources | BNET
On GameSpot: Wii Fit tells 10-year-old she's fat

BNET Industries

Johnson & Johnson (JNJ) is in the Pharma Industry

Market Cap
Nov 20 2008
$154.8B

Latest News and Analysis

Additional Resources

  • Research and Markets: This Pharma Company Profile on Johnson and Johnson is Now Available

    DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/a47682/pharma_company_pro) has announced the addition of the "Pharma Company Profiles - Johnson and Johnson" report to their offering. The success of pharmaceutical companies has always been driven by the successful launches of blockbusters. Now the environment confronting the industry is getting increasingly...

    Articles 2008-11-12

  • Family Finance

    Byline: By TONY HETHERINGTON Q: I appreciate that up to pounds 50,000 in the bank is now protected, but what is the position regarding other investments, such as bonds held with Prudential? J.J. A: You are right that pounds 50,000 in cash in the bank is...

    Articles 2008-11-12

  • J.S. Hovnanian & Sons Broke Records At The 2008 MAME Awards

    MOUNT LAUREL, N.J. -- J.S. Hovnanian & Sons had a banner year at this year's MAME Awards on November 5, winning a record-breaking 23 awards - more than any other builder - for their communities in South Jersey. The MAME Major Achievement in Marketing Excellence Awards, presented by...

    Articles 2008-11-10

  • Seven Summits Research Releases Alerts on CSCO, JNJ, APC, RF, and CI

    CHICAGO, Nov. 10 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks. Seven Summits Strategic Investments' PriceWatch Alerts are available at http://www.iotogo.com/s/111008A (Note: You may have to copy this link into your browser then press the [ENTER] key.) Today's PriceWatch Alerts...

    Articles 2008-11-10

  • Paladin Reports Record Third Quarter 2008 Financial Results

    Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, today reported its third quarter 2008 financial results. Third Quarter Highlights - Revenues reached $22.2 million, an increase of 31% versus last year - EBITDA(1) reached $9.2 million, an 81% increase over the same period last year - Acquired...

    Articles 2008-11-06

  • page 1 of 1
  • Incorporated: 1887
  • CEO: Mr. William C. Weldon

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the health care field. As of Dec 31 2007, Co. operated through three segments. Co.'s Consumer segment includes a range of products used in the baby and child care, skin care, oral and wound care and women's health care fields, as well as nutritional and over-the-counter pharmaceutical products. Co.'s Pharmaceutical segment includes a range of products used in therapeutics areas. Co.'s Medical Devices and Diagnostics segment includes a range of products used primarily in the professional fields by physicians, nurses, therapists, hospitals, diagnostic laboratories and clinics.

Key Competitors

advertisement
Johnson & Johnson Company Info

Board of Directors

Mr. William C. Weldon

Chairman

Mr. Charles Prince

Dr. David Satcher Ph.D.

Ms. Christine A. Poon

Vice-Chairman

Mr. James G. Cullen

Presiding Director

Dr. Mary Sue Coleman Ph.D.

Dr. Michael M. E. Johns M.D.

Mr. Arnold G. Langbo

Dr. Susan L. Lindquist Ph.D.

Mr. Leo F. Mullin

Mr. William D. Perez

Contact Information

One Johnson & Johnson Plaza

New Brunswick, NJ

http://www.jnj.com

732 524 0400

NAICS Code

Pharmaceutical Preparation Manufacturing: 325412
advertisement